European Journal of Epidemiology

, Volume 19, Issue 11, pp 1029–1036 | Cite as

Body mass index and serum folate in childbearing age women

  • Ramin Mojtabai
Article

Abstract

Background: Higher pre-pregnancy body mass index (BMI) is associated with increased risk of neural tube defects (NTDs) and possibly other negative birth outcomes in the offspring. The mechanism for this association remains unknown. Lower maternal folate level has been implicated in the etiology of NTDs in general. The association of BMI␣with folate level, however, has not been investigated. Methods: The present study examines the association of BMI with folate level in childbearing age women before and after the 1998 U.S. folate fortification program of cereal products, using data from two cross-sectional surveys of the␣U.S. population, the third wave of the National␣Health and Nutrition Examination Survey (NHANES III; 1988–1994) and the more recent wave of this survey (NHANES 1999–2000). Results: After controlling for intake of folate in food and nutritional supplements, increased BMI in childbearing age women was associated with a lower serum folate level in both surveys (p < 0.001). Using data from NHANES 1999–2000, it was estimated that women in the 30.0+ kg/m2 BMI category would need to take an additional 350 μg/day of folate to achieve the same serum folate level as women in the < 20.0 kg/ma2 category. Conclusion: Lower folate level may be one mechanism linking higher maternal BMI and increased risk of NTDs in the offspring. If corroborated in future studies, findings from this study suggest a need for a higher dose of folate supplement in heavier childbearing age women.

Body mass index Folate Neural tube defects Obesity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Waller DK, Mills JL, Simpson JL, et al. Are obese women at higher risk for producing malformed offspring? Am J Obstet Gynecol 1994; 170: 541–548.Google Scholar
  2. 2.
    Shaw GM, Velie EM, Schaffer D. Risk of neural tube defect-a. ected pregnancies among obese women. JAMA 1996; 275: 1093–1096.Google Scholar
  3. 3.
    Shaw GM, Todoro K, Schaffer DM, Selvin S. Maternal height and prepregnancy body mass index as risk factors for selected congenital anomalies. Pediatr Perinat Epidemiol 2000; 14: 234–239.Google Scholar
  4. 4.
    Watkins ML, Scanlon KS, Mulinare J, Khoury MJ. Is maternal obesity a risk factor for anencephaly and spina bi da? Epidemiology 1996; 7: 507–512.Google Scholar
  5. 5.
    Werler MM, Louik C, Shapiro S, Mitchell AA. Pre-pregnant weight in relation to risk of neural tube de-fects. JAMA 1996; 275: 1089–1092.Google Scholar
  6. 6.
    Kallen K. Maternal smoking, body mass index, and neural tube defects. Am J Epidemiol 1998; 147: 1103–1111.Google Scholar
  7. 7.
    Shaw GM, Nelson V, Moore CA. Prepregnancy body mass index and risk of multiple congenital anomalies. Am J Med Genet 2002; 107: 253–255.Google Scholar
  8. 8.
    Scholl TO, Johnson WG. Folic acid: Influence on the outcome of pregnancy. Am J Clin Nutr 2000; 71(5 Suppl): 295S–303S.Google Scholar
  9. 9.
    Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics 2003; 111: 1152–1158.Google Scholar
  10. 10.
    Jones PB, Rantakallio P, Hartikainen AL, Isohanni M, Sipila P. Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: A 28-year follow-up of the 1966 north Finland general population birth cohort. Am J Psychiatry 1998; 155: 355–364.Google Scholar
  11. 11.
    Schaefer CA, Brown AS, Wyatt RJ, et al. Maternal prepregnant body mass and risk of schizophrenia in adult offspring. Schizophr Bull 2000; 26: 275–286.Google Scholar
  12. 12.
    Botto LD, Moore CA, Khoury MJ, Erickson JD. Neu-ral-tube defects. N Eng J Med 1999; 341: 1509–1519.Google Scholar
  13. 13.
    Green NS. Folic acid supplementation and prevention of birth defects. J Nutr 2002; 132(8 Suppl): 2356S–2360S.Google Scholar
  14. 14.
    Pietrzik KF, Thorand B. Folate economy in pregnancy. Nutrition 1997; 13: 975–977.Google Scholar
  15. 15.
    Wild J, Schorah CJ, Sheldon TA, Smithells RW. Investigation of factors influencing folate status in women who have had a neural tube defect-affected infant. Br J Obstet Gynaecol 1993; 100: 546–549.Google Scholar
  16. 16.
    Wild J, Seller MJ, Schorah CJ, Smithells RW. Inves-tigation of folate intake and metabolism in women who have had two pregnancies complicated by neural tube defects. Br J Obstet Gynaecol 1994; 101: 197–202.Google Scholar
  17. 17.
    Neuhouser ML, Beresford SA, Hickok DE, Monsen ER. Absorption of dietary and supplemental folate in women with prior pregnancies with neural tube defects and controls. J Am Coll Nutr 1998; 17: 625–630.Google Scholar
  18. 18.
    Flegal KMC, Ogden CL, Johnson, CL. Prevalence and trends in obesity among US Adults, 1999–2000. JAMA 2003; 288: 1723–1727.Google Scholar
  19. 19.
    Institute of Medicine. Dietary reference intakes for thiamine, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academy Press, 2000.Google Scholar
  20. 20.
    Prevention of neural tube defects: Results of the Med-ical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991; 338: 131–137.Google Scholar
  21. 21.
    National Center for Health Statistics. The third Na-tional Health and Nutrition Examination Survey (NHANES III, 1988–94), 1996 (http://www.cdc.gov/nchs/about/major/nhanes/NHANESIII_Reference_Manuals.htm).Google Scholar
  22. 22.
    National Center for Health Statistics. NHANES 1999–2000 data files, 2002 (http://www.cdc.gov/nchs/about/major/nhanes/NHANES99_00.htm).Google Scholar
  23. 23.
    Erickson JD, Mulinare J, Yang Q, et al. Folate status in women of childbearing age, by race/ethnicity–United States, 1999–2000. Morb Mortal Wkly Rep 2002; 51: 808–810.Google Scholar
  24. 24.
    Lawrence JM, Petitti DB, Watkins M, Umekubo MA. Trends in serum folate after food fortication. Lancet 1999; 354: 915–916.Google Scholar
  25. 25.
    Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortication on plasma folate and total homocysteine concentrations. N Eng J Med 1999; 340: 1449–1454.Google Scholar
  26. 26.
    Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US chil-dren and adolescents, 1999–2000. JAMA 2002; 288: 1728–1732.Google Scholar
  27. 27.
    Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002; 288: 1723–1727.Google Scholar
  28. 28.
    Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 2004; 291: 2847–2850.Google Scholar
  29. 29.
    National Center for Health Statistics. National Health and Nutrition Examination Survey III: Body Mea-surements (Anthropometry): Westat, Inc., 1988 (http://www.cdc.gov/nchs/data/nhanes/nhanes3/cdrom/nchs/manuals/anthro.pdf).Google Scholar
  30. 30.
    Institute of Medicine. Nutrition during pregnancy. Washington, DC: National Academy Press, 1990.Google Scholar
  31. 31.
    National Center for Health Statistics. NHANES 1999–2000 data release (June 2002)Dietary interview com-ponent total nutrient intakes file, 2002 (http://www.cdc.gov/nchs/data/nhanes/frequency/drxtodoc.pdf).Google Scholar
  32. 32.
    National Center for Health Statistics. NHANES 1999–2000 Second public release dataset–laboratory 06, 2003 (http://www.cdc.gov/nchs/data/nhanes/frequency/l06doc.pdf).Google Scholar
  33. 33.
    Gunter EW, Lewis BG, Koncikowski SM. Laboratory procedures used for the third National Health and Nutrition Examination Survey (NHANES III), 1988–1994, 1996 (http://www.cdc.gov/nchs/data/nhanes/nhanes3/cdrom/nchs/manuals/labman.pdf).Google Scholar
  34. 34.
    Wald NJ, Law MR, Morris JK, Wald DS. Quanti-fying the effect of folic acid. Lancet 2001; 358: 2069–2073.Google Scholar
  35. 35.
    StataCorp. Stata statistical software, release 7. 0. College Station, TX: Stata Corporation, 2001.Google Scholar
  36. 36.
    Hendricks KA, Nuno OM, Suarez L, Larsen R. Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology 2001; 12: 630–635.Google Scholar
  37. 37.
    Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: A population-based case–control study. Pediatrics 1990; 85: 1–9.Google Scholar
  38. 38.
    Aberg A, Rydhstrom H, Kallen B, Kallen K. Impaired glucose tolerance during pregnancy is associated with increased fetal mortality in preceding sibs. Acta Obstet Gynecol Scand 1997; 76: 212–217.Google Scholar
  39. 39.
    Groenen PM, Peer PG, Wevers RA, et al. Maternal myo-inositol, glucose, and zinc status is associated with the risk of offspring with spina bifida. Am J Obstet Gynecol 2003; 189: 1713–1719.Google Scholar
  40. 40.
    Shaw GM, Quach T, Nelson V, et al. Neural tube de-fects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am J Clin Nutr 2003; 78: 972–978.Google Scholar
  41. 41.
    Correa AB, Liu Y, Mulinare J, Erickson JD. Do multivitamin supplements attenuate the risk of diabetes-associated birth defects? Pediatrics 2003; 111: 1146–1151.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Ramin Mojtabai
    • 1
  1. 1.Department of Psychiatry, Beth Israel Medical CenterNew York, NYUSA (

Personalised recommendations